Literature DB >> 33364692

Multiple Intracranial Lesions in Brain-Differential Diagnosis in a Lady of Reproductive Age: Case Report and Review of Literature.

Ajit Mishra1, Subhas K Konar1, Shilpa Rao2, Nishanth Sadashiva1, B Indira Devi1.   

Abstract

Year:  2020        PMID： 33364692      PMCID： PMC7732890          DOI： 10.1007/s13193-020-01140-4

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


× No keyword cloud information.
  10 in total

1.  Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis.

Authors:  U Ernemann; M Skalej; M Hermisson; M Platten; R Jaffe; K Voigt
Journal:  Neuroradiology       Date:  2002-07-25       Impact factor: 2.804

2.  Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease.

Authors:  P Sedrak; L Ketonen; P Hou; N Guha-Thakurta; M D Williams; R Kurzrock; J M Debnam
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

Review 3.  Surgical treatment of intracranial Erdheim-Chester disease.

Authors:  Alex Alfieri; Roberto Gazzeri; Marcelo Galarza; Massimiliano Neroni
Journal:  J Clin Neurosci       Date:  2010-09-16       Impact factor: 1.961

Review 4.  Erdheim-Chester disease mimicking an intracranial trigeminal schwannoma: case report.

Authors:  Maysam Alimohamadi; Christian Hartmann; Vincenzo Paterno; Madjid Samii
Journal:  J Neurosurg Pediatr       Date:  2015-02-27       Impact factor: 2.375

5.  MRI and CT findings of isolated intracranial Rosai-Dorfman disease in a child.

Authors:  Ayse G Alimli; Cigdem Oztunali; Oznur L Boyunaga; Selma Pamukcuoglu; Arzu Okur; Alp O Borcek
Journal:  Neuroradiol J       Date:  2016-02-25

6.  High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

Authors:  Julien Haroche; Frédéric Charlotte; Laurent Arnaud; Andreas von Deimling; Zofia Hélias-Rodzewicz; Baptiste Hervier; Fleur Cohen-Aubart; David Launay; Annette Lesot; Karima Mokhtari; Danielle Canioni; Louise Galmiche; Christian Rose; Marc Schmalzing; Sandra Croockewit; Marianne Kambouchner; Marie-Christine Copin; Sylvie Fraitag; Felix Sahm; Nicole Brousse; Zahir Amoura; Jean Donadieu; Jean-François Emile
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

Review 7.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

8.  Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

Authors:  Jochen Utikal; Selma Ugurel; Hjalmar Kurzen; Philipp Erben; Andreas Reiter; Andreas Hochhaus; Thomas Nebe; Ralf Hildenbrand; Uwe Haberkorn; Sergij Goerdt; Dirk Schadendorf
Journal:  Arch Dermatol       Date:  2007-06

9.  Erdheim-chester disease mimicking multiple meningiomas syndrome.

Authors:  Mahlon D Johnson; Joseph P Aulino; Madan Jagasia; Louise A Mawn
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

10.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Authors:  Marie-Luise Berres; Karen Phaik Har Lim; Tricia Peters; Jeremy Price; Hitoshi Takizawa; Hélène Salmon; Juliana Idoyaga; Albert Ruzo; Philip J Lupo; M John Hicks; Albert Shih; Stephen J Simko; Harshal Abhyankar; Rikhia Chakraborty; Marylene Leboeuf; Monique Beltrão; Sérgio A Lira; Kenneth M Heym; Venetia Bigley; Matthew Collin; Markus G Manz; Kenneth McClain; Miriam Merad; Carl E Allen
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.